Search by Drug Name or NDC
NDC 61919-0186-07 PHENTERMINE HYDROCHLORIDE 37.5 mg/1 Details
PHENTERMINE HYDROCHLORIDE 37.5 mg/1
PHENTERMINE HYDROCHLORIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is PHENTERMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Phentermine is used for a limited period of time to speed weight loss in overweight people who are exercising and eating a low-calorie diet. Phentermine is in a class of medications called anorectics. It works by decreasing appetite.
Related Packages: 61919-0186-07Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Phentermine
Product Information
| NDC | 61919-0186 |
|---|---|
| Product ID | 61919-186_f9261f0d-fcef-339c-e053-6394a90a6f51 |
| Associated GPIs | 61200070100310 |
| GCN Sequence Number | 005159 |
| GCN Sequence Number Description | phentermine HCl TABLET 37.5 MG ORAL |
| HIC3 | J8A |
| HIC3 Description | ANTI-OBESITY - ANOREXIC AGENTS |
| GCN | 20713 |
| HICL Sequence Number | 002111 |
| HICL Sequence Number Description | PHENTERMINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | PHENTERMINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | PHENTERMINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 37.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | PHENTERMINE HYDROCHLORIDE |
| Labeler Name | Direct_Rx |
| Pharmaceutical Class | Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA040555 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61919-0186-07 (61919018607)
| NDC Package Code | 61919-186-07 |
|---|---|
| Billing NDC | 61919018607 |
| Package | 7 TABLET in 1 BOTTLE (61919-186-07) |
| Marketing Start Date | 2020-10-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |